dr. elli papaemmanuil | ash 2017 | classification and risk assessment in aml
Published 6 years ago • 2.8K plays • Length 2:08Download video MP4
Download video MP3
Similar videos
-
17:26
the v foundation virtual scientific conference - dr. elli papaemmanuil
-
1:05
prof. ross levine | ash 2017 | molecular pathogenesis of aml
-
4:34
prof. gail roboz | ash 2017 | new hope in aml: ngs, ch and mrd
-
2:55
prof. uwe platzbecker | ash 2017 | mrd guided treatment in aml: the relaza2 trial
-
2:42
prof. gert ossenkoppele | ash 2017 | venetoclax in aml
-
3:51
assessing high-risk aml
-
3:24
prof. mark levis | ash 2017 | overview of flt3 inhibitors in aml
-
37:37
keynote address at the acams 16th annual aml & financial crime conference
-
1:15:38
hot topics in aml and financial crime in 2017
-
1:16:47
panel on canada's draft aml regulations for virtual currency
-
7:19
ifcc clinical case 2:malaysia lee bee sun
-
2:15
prof. selina luger | ash 2017 | improving standard therapy in aml
-
6:03
prof. norbert vey | ash 2017 | key findings from the effikir trial: lirilumab in aml
-
24:11
dr. david sanford - aml research update
-
28:16
insufficient levels of pms2, ercc1, ku86, and ccoi contribute in the progression of colon cancer
-
3:41
prof. eunice wang | ash 2017 | crenolanib and sc in young newly diagnosed flt3 mutated aml
-
6:31
a meta-analysis assessing the safety of cytoreductive therapies in younger patients with pv
-
2:33
what is acute myeloid leukemia (aml)? english
-
10:33
apasl stc 2018 yokohama: dr. laurentius a. lesmana
-
2:00
2007 albert lasker basic medical research award - the immune system and cancer
-
3:59
understanding risk in aml: how molecular testing affects treatment options